>_ QFI Terminal
Terminal › Stocks › NEOG

Neogen Corporation (NEOG) Stock

Healthcare · Medical - Devices · US
$11.60 -0.60%
Last updated Nov 12, 2026 09:32 UTC

NEOG Key Statistics

Market Cap$2.53B
P/E (TTM)-46.05
P/S (TTM)2.86
P/B (TTM)1.21
Revenue (TTM)$883.99M
EPS (TTM)$-0.25
Dividend Yield—
ROE (TTM)-2.68%
Net Margin-6.35%
Gross Margin47.40%
52W High$14.26
52W Low$5.37
Analyst ViewBuy
Price Target$13.50
Employees2,636
Volume2,959,209

About Neogen Corporation

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

CEO: Mikhael Nassif. Company website

NEOG — Frequently Asked Questions

What is the NEOG stock price today?

Neogen Corporation (NEOG) trades at $11.60, down 0.60% on the day, as of Nov 12, 2026 09:32 UTC.

What is Neogen Corporation's market cap?

Neogen Corporation has a market capitalisation of $2.53B, calculated from the live NEOG share price and shares outstanding.

What is the P/E ratio of NEOG?

NEOG has no meaningful price-to-earnings ratio: Neogen Corporation lost $0.25 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Neogen Corporation make?

Neogen Corporation generated revenue of $883.99M over the trailing twelve months, which puts the stock at 2.86 times sales.

What is the 52-week range for NEOG?

NEOG has traded between $5.37 and $14.26 over the past 52 weeks, and the last price is 18.7% below that high.

Is Neogen Corporation profitable?

No. Neogen Corporation is loss-making, with a net margin of -6.35% over the trailing twelve months.

What is the analyst price target for NEOG?

Wall Street analysts rate NEOG Buy, with an average price target of $13.50, 16.4% above the current price.

What sector is Neogen Corporation in?

Neogen Corporation is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US.

Who is the CEO of Neogen Corporation?

Mikhael Nassif is the chief executive of Neogen Corporation, which employs 2,636 people.

Where can I track NEOG in real time?

QFI Terminal shows NEOG with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See NEOG live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open NEOG in Terminal See plans

Medical - Devices stocks

ABT Abbott Laboratories MDT Medtronic Plc SYK Stryker Corporation GEHC GE HealthCare Technologies Inc. BSX Boston Scientific Corporation ZBH Zimmer Biomet Holdings, Inc. EW Edwards Lifesciences Corporation SNN Smith & Nephew plc DXCM DexCom, Inc. ALGN Align Technology, Inc. BRKR Bruker Corporation PODD Insulet Corp. GMED Globus Medical, Inc. BIO Bio-Rad Laboratories, Inc. ITGR Integer Holdings Corporation IART Integra LifeSciences Holdings Corporation PEN Penumbra, Inc. HAE Haemonetics Corporation TNDM Tandem Diabetes Care, Inc. TMDX TransMedics Group, Inc. AVNS Avanos Medical, Inc. GKOS Glaukos Corporation INMD InMode Ltd. PRCT PROCEPT BioRobotics Corporation

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.

ETFs holding NEOG

IJR iShares Core S&P Small-Cap ETF 0.15% IWM iShares Russell 2000 ETF 0.09% SCHA Schwab U.S. Small-Cap ETF 0.06% VTI Vanguard Morningstar Total Stock Market ETF 0.00% SCHB Schwab U.S. Broad Market ETF 0.00%

Largest institutional holders of NEOG

BlackRock, Inc. BLK 33,431,015 shares
Neuberger Berman Group LLC 16,570,795 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 13,038,732 shares
DIMENSIONAL FUND ADVISORS LP 10,284,598 shares
VANGUARD CAPITAL MANAGEMENT LLC 9,655,248 shares
SG Americas Securities, LLC 9,352,065 shares
T. Rowe Price Investment Management, Inc. 9,333,261 shares
STATE STREET CORP STT 8,946,377 shares
ING GROEP NV 8,748,343 shares
Gates Capital Management, Inc. 8,742,274 shares

NEOG insiders on other boards

AGIO Agios Pharmaceuticals, Inc. Capello Jeffrey D CDNA CareDx, Inc Riggsbee Richard Bryan BRKR Bruker Corporation Bernard Thierry ADI Analog Devices, Inc. Wainer Andrea F